Sandbox: hyperthyroidism 2: Difference between revisions
Ahmed Younes (talk | contribs) No edit summary |
Ahmed Younes (talk | contribs) No edit summary |
||
Line 9: | Line 9: | ||
{{familytree | | | | | | | | | |!| | | | | | | | }} | {{familytree | | | | | | | | | |!| | | | | | | | }} | ||
{{familytree | | |,|-|-|-|-|-|-|+|-|-|-|-|-|-|.| }} | {{familytree | | |,|-|-|-|-|-|-|+|-|-|-|-|-|-|.| }} | ||
{{familytree | | B01 | | | | | B02 | | | | | B03 |B01='''Primary'''|B02='''Secondary'''|B03='''Tertiary'''|}} | {{familytree | | B01 | | | | | B02 | | | | | B03 |B01='''Primary hyperthytoidism'''|B02='''Secondary hyperthyroidism'''|B03='''Tertiary hyoperthyroidism'''|}} | ||
{{familytree | | |!| | | | | | |!| | | | | | |!| |}} | {{familytree | | |!| | | | | | |!| | | | | | |!| |}} | ||
{{familytree | |boxstyle=text-align: left; | C01 | | | | | C02 | | | | | C03 | |C01=• | {{familytree | |boxstyle=text-align: left; | C01 | | | | | C02 | | | | | C03 | |C01=•[[Graves' disease|Grave’s disease]]<br>• [[Toxic thyroid nodule]]<br>• [[Thyroid adenoma]]<br>• [[Multinodular goiter]]|C02=• [[Pituitary adenoma]]<br>• [[Intracranial tumor|Intracranial tumors]] pressing [[pituitary gland]]|C03=• Excess thyroxin production due to disorders of the [[hypothalamus]] which may be due to [[Intracranial tumor|intracranial tumors]] or [[Intracranial mass|masses]].}} | ||
{{familytree\end}} | {{familytree\end}} | ||
Revision as of 16:46, 11 August 2017
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [2]
Differentiating hyperthyroidism from other diseases
According to the origin of the abnormality | |||||||||||||||||||||||||||||||||||||
Primary hyperthytoidism | Secondary hyperthyroidism | Tertiary hyoperthyroidism | |||||||||||||||||||||||||||||||||||
•Grave’s disease • Toxic thyroid nodule • Thyroid adenoma • Multinodular goiter | • Pituitary adenoma • Intracranial tumors pressing pituitary gland | • Excess thyroxin production due to disorders of the hypothalamus which may be due to intracranial tumors or masses. | |||||||||||||||||||||||||||||||||||
According to Iodine uptake | |||||||||||||||||||||||||||||||||||||
High iodine uptake | High or normal uptake | Low uptake | |||||||||||||||||||||||||||||||||||
• A • B • C | • E • F • G • H | • A • B • C • E • F • G • H | |||||||||||||||||||||||||||||||||||
Disease | Prominent clinical features | Lab findings | Images | |||
---|---|---|---|---|---|---|
Hyperthyroidism | The main symptoms include:
|
|
||||
Essential hypertension | Most patients with hypertension are asymptomatic at the time of diagnosis. Common symptoms are listed below: | JNC 7 recommends the following routine laboratory tests before initiation of therapy for hypertension:
|
- | |||
Generalized anxiety disorder | DSM-V Diagnostic Criteria for Generalized Anxiety Disorder
|
- | - | |||
Menopausal symptoms | The perimenopause symptoms are caused by an overall drop, as well as dramatic but erratic fluctuations, in the levels of estrogens, progestin, and testosterone. Some of these symptoms such as formication etc may be associated with the hormone withdrawal process.
Vasomotor instability
Urogenital atrophy
Skeletal
Skin, soft tissue
Psychological Sexual
|
- | ||||
Opioid withdrawal disorder |
DSM-V Diagnostic Criteria for Opioid Withdrawal
|
|
- | |||
Pheochromocytoma | The hallmark symptoms of a pheochromocytoma are those of sympathetic nervous system hyperactivity, symptoms usually subside in less than one hour and they may include:
Please note that not all patients with pheochromocytoma experience all classical symptoms. |
Diagnostic lab findings associated with pheochromocytoma include:
|